TrialCritical care (London, England)2022

Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial.

Andrew James Boyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.